Correlation Between CytomX Therapeutics and Wave Life

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both CytomX Therapeutics and Wave Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CytomX Therapeutics and Wave Life into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CytomX Therapeutics and Wave Life Sciences, you can compare the effects of market volatilities on CytomX Therapeutics and Wave Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CytomX Therapeutics with a short position of Wave Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of CytomX Therapeutics and Wave Life.

Diversification Opportunities for CytomX Therapeutics and Wave Life

0.94
  Correlation Coefficient

Almost no diversification

The 3 months correlation between CytomX and Wave is 0.94. Overlapping area represents the amount of risk that can be diversified away by holding CytomX Therapeutics and Wave Life Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Wave Life Sciences and CytomX Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CytomX Therapeutics are associated (or correlated) with Wave Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Wave Life Sciences has no effect on the direction of CytomX Therapeutics i.e., CytomX Therapeutics and Wave Life go up and down completely randomly.

Pair Corralation between CytomX Therapeutics and Wave Life

Given the investment horizon of 90 days CytomX Therapeutics is expected to under-perform the Wave Life. In addition to that, CytomX Therapeutics is 1.12 times more volatile than Wave Life Sciences. It trades about -0.17 of its total potential returns per unit of risk. Wave Life Sciences is currently generating about -0.12 per unit of volatility. If you would invest  1,290  in Wave Life Sciences on December 27, 2024 and sell it today you would lose (389.00) from holding Wave Life Sciences or give up 30.16% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Strong
Accuracy100.0%
ValuesDaily Returns

CytomX Therapeutics  vs.  Wave Life Sciences

 Performance 
       Timeline  
CytomX Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days CytomX Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's primary indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Wave Life Sciences 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Wave Life Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

CytomX Therapeutics and Wave Life Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with CytomX Therapeutics and Wave Life

The main advantage of trading using opposite CytomX Therapeutics and Wave Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CytomX Therapeutics position performs unexpectedly, Wave Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Wave Life will offset losses from the drop in Wave Life's long position.
The idea behind CytomX Therapeutics and Wave Life Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Complementary Tools

Money Managers
Screen money managers from public funds and ETFs managed around the world
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios